CDXC Nov 2024 7.500 call
| Previous Close | 0.4500 |
| Open | 0.4500 |
| Bid | 0.0000 |
| Ask | 0.5000 |
| Strike | 7.50 |
| Expire Date | 2024-11-15 |
| Day's Range | 0.4500 - 0.4500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 605 |
Business WireChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award
LOS ANGELES, May 22, 2024--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, is proud to announce that its flagship ingredient, Niagen® (patented nicotinamide riboside, NR), the most efficient and high-quality NAD+ booster and the active ingredient in the company’s consumer supplement, Tru Niagen®, has been awarded the NutraIngredients EU Healthy Ageing Ingredient of the Year Award. This recognition underscores the signifi
GuruFocus.comChromaDex Corp (CDXC) Q1 2024 Earnings: Aligns with EPS Projections, Misses Revenue Estimates
Insights into ChromaDex's First Quarter Financial Performance and Strategic Initiatives
Insider MonkeyChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript
ChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript May 8, 2024 ChromaDex Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. And welcome to ChromaDex Corporation’s First Quarter of 2024 Earnings Conference […]
